David Broemeling

Vice President, Operations, NanoVation Therapeutics

David Broemeling is a proven and successful entrepreneur and executive in the life sciences and diagnostics industries with over 20 years of experience in strategy, business development, marketing, operations and finance roles. He was co-founder of Boreal Genomics, a UBC spin-off company which developed platform technologies for life science research and oncology diagnostics. Boreal raised over $25M USD in venture capital, and $10M in non-dilutive funding, which resulted in two separate M&A exits to global leaders in their respective industries. David holds a bachelor’s of applied science in engineering physics from UBC.